T-Cell Engagers in Solid Cancers—Current Landscape and Future Directions

SIMPLE SUMMARY: There are multiple strategies to target cancer cells, and among the rapidly evolving field is the use of bispecific antibodies and T-cell engagers in the treatment of cancers. These drugs work by recruiting and activating T-cells, a type of white blood cell, to recognize and attack c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanshal, Mohamed, Caimi, Paolo F., Adjei, Alex A., Ma, Wen Wee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216491/
https://www.ncbi.nlm.nih.gov/pubmed/37345160
http://dx.doi.org/10.3390/cancers15102824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216491/
https://www.ncbi.nlm.nih.gov/pubmed/37345160
http://dx.doi.org/10.3390/cancers15102824

Ejemplares similares